Danielle Kwiatkowski

480 total citations
4 papers, 80 citations indexed

About

Danielle Kwiatkowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Danielle Kwiatkowski has authored 4 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Genetics. Recurrent topics in Danielle Kwiatkowski's work include HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer-related Molecular Pathways (1 paper). Danielle Kwiatkowski is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer-related Molecular Pathways (1 paper). Danielle Kwiatkowski collaborates with scholars based in United States and Germany. Danielle Kwiatkowski's co-authors include Gabriel N. Hortobágyi, Carol Rosenblum, A. Broxson, Jennifer K. Litton, Limin Hsu, Lynne Nguyen, Karin Hahn, Leslie R. Schover, Mark F. Munsell and Phuong K. Morrow and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Clinical Breast Cancer.

In The Last Decade

Danielle Kwiatkowski

4 papers receiving 79 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Kwiatkowski United States 4 58 18 18 17 12 4 80
Roi Tschernichovsky Israel 5 33 0.6× 24 1.3× 14 0.8× 24 1.4× 8 0.7× 17 101
David Arons United States 3 23 0.4× 14 0.8× 23 1.3× 20 1.2× 9 0.8× 7 116
G.S. Bhattacharyya India 5 47 0.8× 17 0.9× 42 2.3× 25 1.5× 3 0.3× 10 102
Jasmine C. Huynh United States 7 50 0.9× 18 1.0× 10 0.6× 24 1.4× 12 1.0× 14 100
D. Zarca France 6 48 0.8× 16 0.9× 43 2.4× 22 1.3× 10 0.8× 9 118
Susan Hasanpour‐Heidari Iran 6 70 1.2× 15 0.8× 18 1.0× 9 0.5× 3 0.3× 13 111
Ljiljana Stamatović Serbia 5 115 2.0× 21 1.2× 27 1.5× 13 0.8× 6 0.5× 21 159
Richard de Boer Australia 6 62 1.1× 12 0.7× 10 0.6× 57 3.4× 9 0.8× 12 118
Ariane Darut‐Jouve France 7 86 1.5× 5 0.3× 49 2.7× 33 1.9× 5 0.4× 11 116
Shen Lao China 6 89 1.5× 50 2.8× 19 1.1× 39 2.3× 7 0.6× 11 172

Countries citing papers authored by Danielle Kwiatkowski

Since Specialization
Citations

This map shows the geographic impact of Danielle Kwiatkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Kwiatkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Kwiatkowski more than expected).

Fields of papers citing papers by Danielle Kwiatkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Kwiatkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Kwiatkowski. The network helps show where Danielle Kwiatkowski may publish in the future.

Co-authorship network of co-authors of Danielle Kwiatkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Kwiatkowski. A scholar is included among the top collaborators of Danielle Kwiatkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Kwiatkowski. Danielle Kwiatkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Raghavendra, Akshara Singareeka, Nicole M. Kettner, Danielle Kwiatkowski, et al.. (2025). Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer. npj Breast Cancer. 11(1). 7–7. 4 indexed citations
2.
3.
Pusztai, Lajos, Stacy L. Moulder, Mehmet Altan, et al.. (2014). Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer. Clinical Cancer Research. 20(20). 5265–5271. 28 indexed citations
4.
Morrow, Phuong K., A. Broxson, Mark F. Munsell, et al.. (2013). Effect of Age and Race On Quality of Life in Young Breast Cancer Survivors. Clinical Breast Cancer. 14(2). e21–e31. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026